These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12659300

  • 21. Leishmania species: evidence for transglutaminase activity and its role in parasite proliferation.
    Brobey RK, Soong L.
    Exp Parasitol; 2006 Oct; 114(2):94-102. PubMed ID: 16620812
    [Abstract] [Full Text] [Related]

  • 22. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.
    Pan AA, McMahon-Pratt D.
    J Immunol; 1988 Apr 01; 140(7):2406-14. PubMed ID: 2450920
    [Abstract] [Full Text] [Related]

  • 23. Characterization of Leishmania (Leishmania) tropica axenic amastigotes.
    Nasereddin A, Schweynoch C, Schonian G, Jaffe CL.
    Acta Trop; 2010 Jan 01; 113(1):72-9. PubMed ID: 19782652
    [Abstract] [Full Text] [Related]

  • 24. Proteinase activities during temperature-induced stage differentiation of species complexes of Leishmania.
    Leon LL, Temporal RM, Soares MJ, Grimaldi Júnior G.
    Acta Trop; 1994 Apr 01; 56(4):289-98. PubMed ID: 8023752
    [Abstract] [Full Text] [Related]

  • 25. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.
    Alexander J, Coombs GH, Mottram JC.
    J Immunol; 1998 Dec 15; 161(12):6794-801. PubMed ID: 9862710
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Expression of cysteine proteinases by metacyclic promastigotes of Leishmania mexicana.
    Bates PA, Robertson CD, Coombs GH.
    J Eukaryot Microbiol; 1994 Dec 15; 41(3):199-203. PubMed ID: 8049682
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Leishmania (L.) amazonensis: fusion between parasitophorous vacuoles in infected bone-marrow derived mouse macrophages.
    Real F, Pouchelet M, Rabinovitch M.
    Exp Parasitol; 2008 May 15; 119(1):15-23. PubMed ID: 18346736
    [Abstract] [Full Text] [Related]

  • 31. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro.
    Vendrame CM, Carvalho MD, Rios FJ, Manuli ER, Petitto-Assis F, Goto H.
    Scand J Immunol; 2007 May 15; 66(2-3):287-96. PubMed ID: 17635806
    [Abstract] [Full Text] [Related]

  • 32. Hydrolysis of L-leucine methyl ester by Leishmania mexicana mexicana amastigote cysteine proteinases.
    Hunter CA, Lockwood BC, Coombs GH.
    Int J Parasitol; 1992 Sep 15; 22(6):711-7. PubMed ID: 1428504
    [Abstract] [Full Text] [Related]

  • 33. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.
    Sacks DL, Hieny S, Sher A.
    J Immunol; 1985 Jul 15; 135(1):564-9. PubMed ID: 2582050
    [Abstract] [Full Text] [Related]

  • 34. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines.
    Daneshvar H, Coombs GH, Hagan P, Phillips RS.
    J Infect Dis; 2003 May 15; 187(10):1662-8. PubMed ID: 12721947
    [Abstract] [Full Text] [Related]

  • 35. Axenic cultivation and partial characterization of Leishmania braziliensis amastigote-like stages.
    Balanco JM, Pral EM, da Silva S, Bijovsky AT, Mortara RA, Alfieri SC.
    Parasitology; 1998 Feb 15; 116 ( Pt 2)():103-13. PubMed ID: 9509020
    [Abstract] [Full Text] [Related]

  • 36. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA, Marco JD, Calvopina M, Kato H, Korenaga M, Hashiguchi Y.
    J Antimicrob Chemother; 2007 Jun 15; 59(6):1123-9. PubMed ID: 17439977
    [Abstract] [Full Text] [Related]

  • 37. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK, Lonardoni MV, Grespan R, Caparroz-Assef SM, Cuman RK, Bersani-Amado CA.
    J Infect; 2005 Aug 15; 51(2):157-64. PubMed ID: 16038768
    [Abstract] [Full Text] [Related]

  • 38. Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.
    Souza-Silva F, Bourguignon SC, Pereira BA, Côrtes LM, de Oliveira LF, Henriques-Pons A, Finkelstein LC, Ferreira VF, Carneiro PF, de Pinho RT, Caffarena ER, Alves CR.
    Antimicrob Agents Chemother; 2015 Apr 15; 59(4):1910-8. PubMed ID: 25583728
    [Abstract] [Full Text] [Related]

  • 39. Interaction of different Leishmania mexicana morphotypes with plasminogen.
    Calcagno M, Avilan L, Colasante C, Berrueta L, Salmen S.
    Parasitol Res; 2002 Nov 15; 88(11):972-8. PubMed ID: 12375162
    [Abstract] [Full Text] [Related]

  • 40. Expression of infection-related genes in parasites and host during murine experimental infection with Leishmania (Leishmania) amazonensis.
    Pereira BA, Britto C, Alves CR.
    Microb Pathog; 2012 Feb 15; 52(2):101-8. PubMed ID: 22178713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.